Biotech Values

[DewDiligence]

Re: Xarelto vs Lovenox in ACS

When I posted #msg-68962285 and the following #msg-68969140, I haven't read the paper and I have to admit that even after reading it I didn't pay attention to the 'median of 4.7 days after the acute incident'. I think you're right that it is very unlikely that in this setting Xarelto will impact on Lovenox in ACS.

It’s even less likely now that the FDA issued a CRL :- )